DK0409435T3 - Heteroarylpiperaziner som antipsykotiske midler - Google Patents
Heteroarylpiperaziner som antipsykotiske midlerInfo
- Publication number
- DK0409435T3 DK0409435T3 DK90307166.0T DK90307166T DK0409435T3 DK 0409435 T3 DK0409435 T3 DK 0409435T3 DK 90307166 T DK90307166 T DK 90307166T DK 0409435 T3 DK0409435 T3 DK 0409435T3
- Authority
- DK
- Denmark
- Prior art keywords
- heteroberl
- piperazines
- antipsychotics
- compounds
- psychosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Gas Separation By Absorption (AREA)
- Treating Waste Gases (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1989/002954 WO1991000863A1 (en) | 1989-07-07 | 1989-07-07 | Heteroaryl piperazine antipsychotic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0409435T3 true DK0409435T3 (da) | 1994-11-21 |
Family
ID=22215102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90307166.0T DK0409435T3 (da) | 1989-07-07 | 1990-06-29 | Heteroarylpiperaziner som antipsykotiske midler |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0409435B1 (da) |
| JP (1) | JPH0717633B2 (da) |
| AT (1) | ATE113282T1 (da) |
| CA (1) | CA2020611A1 (da) |
| DE (1) | DE69013601T2 (da) |
| DK (1) | DK0409435T3 (da) |
| ES (1) | ES2062374T3 (da) |
| FI (1) | FI920023A7 (da) |
| IE (1) | IE63134B1 (da) |
| PT (1) | PT94608A (da) |
| WO (1) | WO1991000863A1 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0179063B1 (ko) * | 1993-02-04 | 1999-03-20 | 사사이 아키라 | 항정신병 작용을 갖는 화합물 |
| FR2761067B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
| OA12923A (en) * | 2002-09-17 | 2006-10-13 | Warner Lambert Co | Heterocyclic substituted piperazines for the treatment of schizophrenia. |
| AU2003260882A1 (en) * | 2002-09-26 | 2004-04-19 | Warner-Lambert Company Llc | Heterocyclic substituted piperazines for the treatment of schizophrenia |
| US7160888B2 (en) * | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| RS53599B1 (sr) | 2005-05-10 | 2015-02-27 | Intermune, Inc. | Piridon derivati za modulaciju stresom aktiviranog sistema proteinskih kinaza |
| AR055203A1 (es) | 2005-08-31 | 2007-08-08 | Otsuka Pharma Co Ltd | Derivados de benzotiofeno con propiedades antipsicoticas |
| WO2008015516A1 (en) * | 2006-07-28 | 2008-02-07 | Pfizer Products Inc. | Fused tricyclic heterocycles for the treatment of schizophrenia |
| WO2008037681A1 (en) | 2006-09-26 | 2008-04-03 | Glaxo Group Limited | 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl] ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc. |
| JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン, インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
| US8686009B2 (en) * | 2009-06-25 | 2014-04-01 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds |
| AU2010266018B2 (en) * | 2009-06-25 | 2014-01-09 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| MX358344B (es) | 2011-03-18 | 2018-08-15 | Alkermes Pharma Ireland Ltd | Composiciones farmaceuticas que comprenden un antipsicotico insoluble en agua y esteres de sorbitan. |
| WO2013088255A1 (en) | 2011-12-15 | 2013-06-20 | Alkermes Pharma Ireland Limited | Prodrugs of secondary amine compounds |
| EP2827868B8 (en) | 2012-03-19 | 2019-12-18 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising fatty acid esters |
| AU2013235523B9 (en) | 2012-03-19 | 2018-01-04 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising glycerol esters |
| NZ630428A (en) | 2012-03-19 | 2017-02-24 | Alkermes Pharma Ireland Ltd | Pharmaceutical compositions comprising benzyl alcohol |
| WO2014080285A2 (en) | 2012-09-19 | 2014-05-30 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
| CN110368360A (zh) | 2014-03-20 | 2019-10-25 | 奥克梅斯制药爱尔兰有限公司 | 具有增加的注射速度的阿立哌唑制剂 |
| JP5714152B2 (ja) * | 2014-03-26 | 2015-05-07 | 江蘇恒誼薬業有限公司 | アラルキルピペリジン(又はピペラジン)誘導体及びその統合失調症治療のための使用 |
| CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
| WO2019173230A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
| CN119454012A (zh) * | 2019-01-28 | 2025-02-18 | 美国雅培糖尿病护理公司 | 检测肌酐的分析物传感器和感测方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721721A (en) * | 1984-12-18 | 1988-01-26 | Rorer Pharmaceutical Corporation | 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses |
| MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
| DE3875073T2 (de) * | 1987-11-20 | 1993-03-11 | Hoechst Roussel Pharma | 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel. |
| US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
| US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
-
1989
- 1989-07-07 WO PCT/US1989/002954 patent/WO1991000863A1/en not_active Ceased
- 1989-07-07 FI FI920023A patent/FI920023A7/fi not_active Application Discontinuation
-
1990
- 1990-06-29 DE DE69013601T patent/DE69013601T2/de not_active Expired - Fee Related
- 1990-06-29 EP EP90307166A patent/EP0409435B1/en not_active Expired - Lifetime
- 1990-06-29 ES ES90307166T patent/ES2062374T3/es not_active Expired - Lifetime
- 1990-06-29 DK DK90307166.0T patent/DK0409435T3/da active
- 1990-06-29 AT AT90307166T patent/ATE113282T1/de not_active IP Right Cessation
- 1990-07-03 JP JP2176120A patent/JPH0717633B2/ja not_active Expired - Lifetime
- 1990-07-05 PT PT94608A patent/PT94608A/pt not_active Application Discontinuation
- 1990-07-06 CA CA002020611A patent/CA2020611A1/en not_active Abandoned
- 1990-07-06 IE IE245090A patent/IE63134B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE63134B1 (en) | 1995-03-22 |
| JPH0717633B2 (ja) | 1995-03-01 |
| ATE113282T1 (de) | 1994-11-15 |
| FI920023A0 (fi) | 1992-01-03 |
| DE69013601D1 (de) | 1994-12-01 |
| WO1991000863A1 (en) | 1991-01-24 |
| EP0409435B1 (en) | 1994-10-26 |
| FI920023A7 (fi) | 1992-01-03 |
| DE69013601T2 (de) | 1995-03-02 |
| EP0409435A1 (en) | 1991-01-23 |
| CA2020611A1 (en) | 1991-01-08 |
| JPH0344388A (ja) | 1991-02-26 |
| IE902450A1 (en) | 1991-02-13 |
| ES2062374T3 (es) | 1994-12-16 |
| PT94608A (pt) | 1991-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0409435T3 (da) | Heteroarylpiperaziner som antipsykotiske midler | |
| ES2058614T3 (es) | 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos. | |
| DE69232665D1 (de) | Neue 4-arylpiperazine und 4-arylpiperidine | |
| ATE168992T1 (de) | 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline | |
| BR1100987A (pt) | Composto, composição farmacêutica da matéria, e, composição veterinária | |
| ATE71095T1 (de) | Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel. | |
| ATE215530T1 (de) | 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel | |
| PT618190E (pt) | 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas | |
| FI890311A0 (fi) | Kemiska foereningar. | |
| ATE144498T1 (de) | Herstellung von substituierten piperidinen | |
| IT1228288B (it) | Composti ad attivita' antiserotoninica | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| PT992509E (pt) | Novos derivados macrolidos | |
| FI881609A0 (fi) | Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| ES2104174T3 (es) | Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos. | |
| FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
| IT1241927B (it) | 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono | |
| DE69222143D1 (de) | Indanderivate | |
| ATE97130T1 (de) | 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln. | |
| DK0381114T3 (da) | Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf | |
| EP0412941A3 (en) | Phospholipids for the treatment of multiple sclerosis |